Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells

Cancer Research

Volumn 63, Issue 2, 2003, Pages 498-504

  Lin, Xiaohui ^a   Nelson, William G ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA CYTIDINE; CYTIDINE DERIVATIVE; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE INHIBITOR; ENZYME INHIBITOR; GENE PRODUCT; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; METHYL CPG BINDING PROTEIN 2; RNA; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CELL STRAIN MCF 7; CHROMATIN; CPG ISLAND; DNA TRANSFECTION; ENZYME INHIBITION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CANCER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN METHYLATION;

ALLELES; BLOTTING, NORTHERN; BREAST NEOPLASMS; CHROMOSOMAL PROTEINS, NON-HISTONE; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; METHYL-CPG-BINDING PROTEIN 2; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; TUMOR CELLS, CULTURED;

EID: 0037439798     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Jones, P. A., and Laird, P. W. Cancer epigenetics comes of age. Nat. Genet., 21: 163-167, 1999.
2. Esteller, M., Corn, P. G., Baylin, S. B., and Herman, J. G. A gene hypermethylation profile of human cancer. Cancer Res., 61: 3225-3229, 2001.
3. Baylin, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., and Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72: 141-196, 1998.
4. Antequera, F., and Bird, A. Number of CpG islands and genes in human and mouse. Proc. Natl. Acad. Sci. USA, 90: 11995-11999, 1993.
5. Bird, A. P. CpG-rich islands and the function of DNA methylation. Nature, 321: 209-213, 1986.
6. Wade, P. A. Methyl CpG-binding proteins and transcriptional repression. Bioessays, 23: 1131-1137, 2001.
7. Bird, A. P., and Wolffe, A. P. Methylation-induced repression-belts, braces, and chromatin. Cell, 99: 451-454, 1999.
8. Lin, X., Tascilar, M., Lee, W. H., Vies, W. J., Lee, B. H., Veeraswamy, R., Asgari, K., Freije, D., van Rees, B., Gage, W. R., Bova, G. S., Isaacs, W. B., Brooks, J. D., DeWeese, T. L., De Marzo, A. M., and Nelson, W. G. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am. J. Pathol., 159: 1815-1826, 2001.
9. Lee, W. H., Isaacs, W. B., Bova, G. S., and Nelson, W. G. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol. Biomark. Prev., 6: 443-450, 1997.
10. Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., and Nelson, W. G. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA. 91: 11733-11737, 1994.
11. Millar, D. S., Ow, K. K., Paul, C. L., Russell, P. J., Molloy, P. L., and Clark, S. J. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene, 18: 1313-1324, 1999.
12. Tchou, J. C., Lin, X., Freije, D., Isaacs, W. B., Brooks, J. D., Rashid, A., De Marzo, A. M., Kanai, Y., Hirohashi, S., and Nelson, W. G. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int. J. Oncol., 16: 663-676, 2000.
13. Esteller, M., Corn, P. G., Urena, J. M., Gabrielson, E., Baylin, S. B., and Herman, J. G. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res., 58: 4515-4518, 1998.
14. Jhaveri, M. S., and Morrow, C. S. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells. Gene, 210: 1-7, 1998.
15. Singal, R., van Wert, J., and Bashambu, M. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. Cancer Res., 61: 4820-4826, 2001.
16. Lin, X., Asgari, K., Putzi, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., De Marzo, A. M., and Nelson, W. G. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi- class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res., 61: 8611-8616, 2001.
17. Borde-Chiche, P., Diedericha, M., Morceau, F., Puga, A., Wellman, M., and Dicato, M. Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cells. Biochem. Pharmacol., 61: 605-612, 2001.
18. Whelan, R. D., Waring, C. J., Wolf, C. R., Hayes, J. D., Hosking, L. K., and Hill, B. T. Over-expression of P-glycoprotein and glutathione S-transferase pi in MCF-7 cells selected for vincristine resistance in vitro. Int. J. Cancer, 52: 241-246, 1992.
19. Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T., Wieand, H. S., O'Brien, E. E., Poplack, D. G., Cossman, J., Myers, C. E., and Cowan, K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res., 49: 1422-1428, 1989.
20. Whelan, R. D., Hosking, L. K., Townsend, A. J., Cowan, K. H., and Hill, B. T. Differential increases in glutathione S-transferase activities in a range of multidrug-resistant human tumor cell lines. Cancer Commun., 1: 359-365, 1989.
21. Jhaveri, M. S., Stephens, T. E., and Morrow, C. S. Role of posttranscriptional processes in the regulation of glutathione S-transferase P1 gene expression in human breast cancer cells. Biochem. Biophys. Res. Commun., 237: 729-734, 1997.
22. Morrow, C. S., Chiu, J., and Cowan, K. H. Postranscriptional control of glutathione S-transferase pi gene expression in human breast cancer cells. J. Biol. Chem., 267: 10544-10550, 1992.
23. Moffat, G. J., McLaren, A. W., and Wolf, C. R. Functional characterization of the transcription silencer element located within the human Pi class glutathione S-transferase promoter. J. Biol. Chem., 271: 20740-20747, 1996.
24. Moffat, G. J., McLaren, A. W., and Wolf, C. R. Involvement of Jun and Fos proteins in regulating transcriptional activation of the human pi class glutathione S-transferase gene in multidrug-resistant MCF7 breast cancer cells. J. Biol. Chem., 269: 16397-16402, 1994.
25. Fairchild, C. R., Ivy, S. P., Kao-Shan, C. S., Whang-Peng, J., Rosen, N., Israel, M. A., Melera, P. W., Cowan, K. H., and Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res., 47: 5141-5148, 1987.
26. Batist, G., Tulpule, A., Sinha, B. K., Katki, A. G., Myers, C. E., and Cowan, K. H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem., 261: 15544-15549, 1986.
27. Ferguson, A. T., Lapidus, R. G., Baylin, S. B., and Davidson, N. E. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. Cancer Res., 55: 2279-2283, 1995.
28. Celano, P., Berchtold, C., and Casero, R. A., Jr. A simplification of the nuclear run-off transcription assay. Biotechniques, 7: 942-944, 1989.
29. De Marzo, A. M., Marchi, V. L., Yang, E. S., Veeraswamy, R., Lin, X., and Nelson, W. G. Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis. Cancer Res., 59: 3855-3860, 1999.
30. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411: 494-498, 2001.
31. Clark, S. J., Harrison, J., Paul, C. L., and Frommer, M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res., 22: 2990-2997, 1994.
32. Millar, D. S., Paul, C. L., Molloy, P. L., and Clark, S. J. A distinct sequence (ATAAA)n separates methylated and unmethylated domains at the 5′-end of the GSTP1 CpG island. J. Biol. Chem., 275: 24893-24899, 2000.
33. Magdinier, F., and Wolffe, A. P. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc. Natl. Acad. Sci. USA, 98: 4990-4995, 2001.
34. Nan, X., Meehan, R. R., and Bird, A. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2. Nucleic Acids Res., 21: 4886-4892, 1993.
35. Wakefield, R. I., Smith, B. O., Nan, X., Free, A., Soteriou, A., Uhrin, D., Bird, A. P., and Barlow, P. N. The solution structure of the domain from MeCP2 that binds to methylated DNA. J. Mol. Biol., 291: 1055-1065, 1999.
36. Hendrich, B., and Bird, A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol. Cell. Biol., 18: 6538-6547, 1998.
37. Cross, S. H., Meehan, R. R., Nan, X., and Bird, A. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins. Nat. Genet., 16: 256-259, 1997.
38. Nan, X., Campoy, F. J., and Bird, A. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88: 471-481, 1997.
39. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., and Bird, A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393: 386-389, 1998.
40. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., and Wolffe, A. P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19: 187-191, 1998.
41. Feng, Q., and Zhang, Y. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev., 15: 827-832, 2001.
42. Zhang, Y., Ng, H. H., Erdjument-Bromage, H., Tempst, P., Bird, A., and Reinberg, D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev., 13: 1924-1935, 1999.
43. Ng, H. H., Zhang, Y., Hendrich, B., Johnson, C. A., Turner, B. M., Erdjument-Bromage, H., Tempst, P., Reinberg, D., and Bird, A. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet., 23: 58-61, 1999.
44. Zhang, Y., LeRoy, G., Seelig, H. P., Lane, W. S., and Reinberg, D. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities. Cell, 95: 279-289, 1998.
45. Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Cote, J., and Wang, W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol. Cell, 2: 851-861, 1998.
46. Rountree, M. R., Bachman, K. E., and Baylin, S. B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet., 25: 269-277, 2000.
47. Tatematsu, K. I., Yamazaki, T., and Ishikawa, F. MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase. Genes Cells, 5: 677-688, 2000.
48. Di Croce, L., Raker, V. A., Corsaro, M., Fazi, F., Fanelli, M., Faretta, M., Fuks, F., Lo Coco, F., Kouzarides, T., Nervi, C., Minucci, S., and Pelicci, P. G. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science, 295: 1079-1082, 2002.
49. Santini, V., Kantarjian, H. M., and Issa, J. P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med., 134: 573-586, 2001.
50. Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V. A., and Bird, A. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev., 15: 710-723, 2001.